Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

Marco Valgimigli, Victor Aboyans, Dominick Angiolillo, Dan Atar, Davide Capodanno, Sigrun Halvorsen, Stefan James, Peter Jüni, Vijay Kunadian, Antonio Landi, Sergio Leonardi, Roxana Mehran, Gilles Montalescot, Eliano Pio Navarese, Josef Niebauer, Angelo Oliva, Raffaele Piccolo, Susanna Price, Robert F. Storey, Heinz VöllerPascal Vranckx, Stephan Windecker, Keith A.A. Fox

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Multiple guidelines and consensus papers have addressed the role of antithrombotic strategies in patients with established coronary artery disease (CAD). Since evidence and terminology continue to evolve, the authors undertook a consensus initiative to guide clinicians to select the optimal antithrombotic regimen for each patient. The aim of this document is to provide an update for clinicians on best antithrombotic strategies in patients with established CAD, classifying each treatment option in relation to the number of antithrombotic drugs irrespective of whether the traditional mechanism of action is expected to mainly inhibit platelets or coagulation cascade. With the aim to reach comprehensiveness of available evidence, we systematically reviewed and performed meta-analyses by means of both direct and indirect comparisons to inform the present consensus document.

Original languageEnglish
Pages (from-to)462-496
Number of pages35
JournalEuropean Heart Journal - Cardiovascular Pharmacotherapy
Volume9
Issue number5
DOIs
StatePublished - 1 Aug 2023

Keywords

  • Acute coronary syndrome
  • Antithrombotic treatment
  • Chronic coronary syndrome
  • Coronary artery disease
  • Percutaneous coronary intervention

Fingerprint

Dive into the research topics of 'Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease'. Together they form a unique fingerprint.

Cite this